stockrow
Saturday 31 October 2026
Export XRN’s income statement to Excel — free account
Chiron Real Estate Inc.
XRN Real Estate Reit Healthcare Facilities
Chiron Real Estate Inc.’s revenue for fiscal 2025 (year ended December 2025) was $148.2 million, up 6.79% from fiscal 2024.
- Revenue
- +4.68%
- EPS
- +9,660.0%
- Free cash flow
- −18.0%
- Total debt
- −9.53%
Quarter to June 2026, against a year earlier
30.37
0.15
−0.49%
Follow XRN
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 10.09 |
P/S ratio |
3.11 | 3.05 | 2.89 | 3.24 | |
P/FCF ratio |
0.00 | 30.34 | 10.78 | 13.22 | |
P/Operating CF |
25.70 | 20.87 | 32.79 | 22.01 | |
P/B ratio |
1.05 | 1.11 | 1.10 | 1.07 | |
Price to Tangible BV |
1.06 | 1.13 | 1.12 | 1.08 | |
EV/Sales |
7.96 | 7.39 | 7.20 | 7.29 | |
EV/EBITDA |
12.32 | 11.15 | 11.11 | 11.26 | |
EV/Operating CF |
15.91 | 14.88 | 14.63 | 14.90 | |
EV/FCF |
(130.16) | 73.65 | 26.90 | 29.80 | |
Quick Ratio |
0.52 | 0.61 | 0.68 | 0.59 | |
Current Ratio |
0.52 | 0.61 | 0.68 | 0.59 | |
Net Debt/EBITDA |
28.60 | 25.28 | 26.89 | 24.87 | |
Debt/Assets |
55.92% | 52.81% | 53.78% | 46.31% | |
Debt/Equity |
1.41 | 1.24 | 1.28 | 0.93 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.12 | |
Operating CF/Net income |
(2.93) | (2.92) | (17.83) | 0.36 | |
Capex/Depreciation |
0.02 | 0.43 | (0.14) | (2.70) | |
Interest Coverage |
1.12 | 1.12 | 1.23 | 1.05 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.05% | 14.31% | 13.37% | 13.14% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
3.24% | 3.67% | 3.23% | 3.47% | |
Graham Net Nets |
(1.68) | (1.55) | (1.61) | (1.36) | |
Graham Number |
0.00 | 0.00 | 0.00 | 54.16 | |
Earnings Yield |
(0.74%) | (2.67%) | (3.36%) | 9.91% | |
Free Cash Flow Yield |
(1.96%) | 3.30% | 9.28% | 7.56% | |
Revenue per Share |
2.78 | 2.87 | 2.88 | 3.00 | |
Operating CF per Share |
1.31 | 1.62 | 1.01 | 1.70 | |
Capex per Share |
0.02 | 0.52 | (0.16) | (3.22) | |
Free Cash Flow per Share |
1.33 | 2.13 | 0.85 | (1.51) | |
Cash per Share |
0.73 | 0.89 | 0.83 | 0.98 | |
Shareholders Equity per Share |
37.77 | 39.62 | 39.34 | 51.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.77 | 39.62 | 39.34 | 51.69 | |
Free Cash Flow |
17.87 | 28.53 | 11.21 | (20.05) | |
Working Capital |
(9.12) | (7.55) | (5.16) | (9.14) | |
Capital Expenditures |
0.30 | 6.90 | (2.14) | (42.61) | |
Net Current Asset Value |
(757.57) | (700.51) | (706.41) | (674.79) | |
EV/EBIT |
34.31 | 29.98 | 30.47 | 30.54 | |
Capex to Sales |
(0.01) | (0.18) | 0.06 | 1.07 | |
Price to Operating Income |
13.43 | 12.35 | 12.21 | 13.55 | |
| Other line items | |||||
Average Payables |
15.58 | 17.38 | 14.77 | 19.99 | |
Average Assets |
1,257.92 | 1,249.48 | 1,253.79 | 1,334.37 | |
Average Common Equity |
460.26 | 443.46 | 429.84 | 456.95 |
Columns are period end dates